Enhanced detection of HER2 through a layer-by-layer strategy using a TiVC MXenes/Au nanocomposite amplified analytical biosensor for precise cancer biomarker monitoring

Author:

Zare Najmeh1,Karimi-Maleh Hassan1,Zhang Zhouxiang1,Wen Yangpin2,Zhong Nianbing3,Fu Li4

Affiliation:

1. University of Electronic Science and Technology of China

2. Jiangxi Agricultural University

3. Chongqing University of Technology

4. Hangzhou Dianzi University

Abstract

Abstract

This research work explores the development and application of layer-by-layer modified electrochemical apta-sensor for the precise monitoring of HER2, a crucial biomarker associated with breast cancer. The surface of the screen-printed carbon electrode was modified with gold nanoparticle (Au-NP) and TiVC MXene catalyst plus Pb2+ loaded aptamer (SPCE/TiVC-MXene/Au NPs/Pb2+-aptamer), which showed a high selectivity and affinity toward HER2 and offered a sensitive detection platform. The MXene nano-layer was synthesized and characterized by FT-IR, MAP, EDS, and TEM methods and used as a substrate to improve electrochemical conductivity and loading of biological recognition element. The difference of stripping signals of the Pb2+ from the SPCE/TiVC-MXene/Au NPs/Pb2+-aptamer before and after incubation in HER2 solution was selected as analytical response to achieve a reliable and quantitative analysis for HER2 concentrations. The results demonstrate a linear dynamic range of 1.0–1200 pg/mL for monitoring of HER2 with limit of detection of 50 fg/mL. Agood affinity of fabricated aptasensor to HER2 in the presence some other biomarkers such as PR, ER, and CEA confirmed the selectivity of the fabricated biosensor towards HER2.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Biomarkers—a general review;Aronson JK;Curr protocols Pharmacol,2017

2. Dave S, Dave A, Radhakrishnan S, Das J, Dave S (2022) Biosensors for healthcare: an artificial intelligence approach, Biosensors for Emerging and Re-Emerging Infectious Diseases 365–383

3. HER2 in breast cancer: a review and update;Krishnamurti U;Adv Anat Pathol,2014

4. HER2 testing: current status and future directions;Perez EA;Cancer Treat Rev,2014

5. Recent advances in nanomaterials-based electrochemical immunosensors and aptasensors for HER2 assessment in breast cancer;Ahirwar R;Microchim Acta,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3